Procept Free Cash Flow from 2010 to 2025
| PRCT Stock | USD 60.90 2.80 4.82% |
Free Cash Flow | First Reported 2020-03-31 | Previous Quarter -19 M | Current Value -33.6 M | Quarterly Volatility 9.3 M |
Check Procept Biorobotics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Procept Biorobotics' main balance sheet or income statement drivers, such as Net Interest Income of 7 M, Interest Income of 11.4 M or Depreciation And Amortization of 4 M, as well as many indicators such as Price To Sales Ratio of 17.76, Dividend Yield of 0.0 or PTB Ratio of 10.96. Procept financial statements analysis is a perfect complement when working with Procept Biorobotics Valuation or Volatility modules.
Procept | Free Cash Flow |
Latest Procept Biorobotics' Free Cash Flow Growth Pattern
Below is the plot of the Free Cash Flow of Procept Biorobotics Corp over the last few years. It is the amount of cash a company generates after accounting for cash outflows to support operations and maintain its capital assets. Procept Biorobotics' Free Cash Flow historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Procept Biorobotics' overall financial position and show how it may be relating to other accounts over time.
| Free Cash Flow | 10 Years Trend |
|
Free Cash Flow |
| Timeline |
Procept Free Cash Flow Regression Statistics
| Arithmetic Mean | (65,591,319) | |
| Geometric Mean | 61,812,884 | |
| Coefficient Of Variation | (40.42) | |
| Mean Deviation | 20,787,978 | |
| Median | (51,429,000) | |
| Standard Deviation | 26,512,908 | |
| Sample Variance | 702.9T | |
| Range | 84.6M | |
| R-Value | (0.73) | |
| Mean Square Error | 354.7T | |
| R-Squared | 0.53 | |
| Significance | 0 | |
| Slope | (4,050,542) | |
| Total Sum of Squares | 10544T |
Procept Free Cash Flow History
Other Fundumenentals of Procept Biorobotics Corp
Procept Biorobotics Free Cash Flow component correlations
About Procept Biorobotics Financial Statements
Procept Biorobotics shareholders use historical fundamental indicators, such as Free Cash Flow, to determine how well the company is positioned to perform in the future. Although Procept Biorobotics investors may analyze each financial statement separately, they are all interrelated. The changes in Procept Biorobotics' assets and liabilities, for example, are also reflected in the revenues and expenses on on Procept Biorobotics' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Free Cash Flow | -103.6 M | -108.8 M | |
| Free Cash Flow Yield | (0.02) | (0.03) | |
| Free Cash Flow Per Share | (1.99) | (2.09) | |
| EV To Free Cash Flow | (38.06) | (39.96) | |
| Price To Free Cash Flows Ratio | (40.50) | (42.53) | |
| Free Cash Flow Operating Cash Flow Ratio | 1.04 | 0.86 |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Procept Stock Analysis
When running Procept Biorobotics' price analysis, check to measure Procept Biorobotics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Procept Biorobotics is operating at the current time. Most of Procept Biorobotics' value examination focuses on studying past and present price action to predict the probability of Procept Biorobotics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Procept Biorobotics' price. Additionally, you may evaluate how the addition of Procept Biorobotics to your portfolios can decrease your overall portfolio volatility.